Bergantim, R.; Peixoto da Silva, S.; Polónia, B.; Barbosa, M.A.G.; Albergaria, A.; Lima, J.; Caires, H.R.; Guimarães, J.E.; Vasconcelos, M.H.
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept. Int. J. Mol. Sci. 2022, 23, 13686.
https://doi.org/10.3390/ijms232213686
AMA Style
Bergantim R, Peixoto da Silva S, Polónia B, Barbosa MAG, Albergaria A, Lima J, Caires HR, Guimarães JE, Vasconcelos MH.
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept. International Journal of Molecular Sciences. 2022; 23(22):13686.
https://doi.org/10.3390/ijms232213686
Chicago/Turabian Style
Bergantim, Rui, Sara Peixoto da Silva, Bárbara Polónia, Mélanie A. G. Barbosa, André Albergaria, Jorge Lima, Hugo R. Caires, José E. Guimarães, and M. Helena Vasconcelos.
2022. "Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept" International Journal of Molecular Sciences 23, no. 22: 13686.
https://doi.org/10.3390/ijms232213686
APA Style
Bergantim, R., Peixoto da Silva, S., Polónia, B., Barbosa, M. A. G., Albergaria, A., Lima, J., Caires, H. R., Guimarães, J. E., & Vasconcelos, M. H.
(2022). Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept. International Journal of Molecular Sciences, 23(22), 13686.
https://doi.org/10.3390/ijms232213686
